麻豆国产AV

Brian Muntean

Associate Professor

Brian Muntean

Associate Professor

Academic Appointment(s)

Medical College of Georgia
Department of Pharmacology and Toxicology

Administration
Department of The Graduate School

  • BMUNTEAN@augusta.edu
  • (706) 721-1926
  • CB 3616

Education

  • Ph.D., Medicinal and Pharmaceutical Chemistry University Of Toledo, 2014

  • Ph.D., Pharmaceutics and Drug Design University Of Toledo, 2014

  • BS, Pharmaceutics and Drug Design University Of Toledo, 2009

  • BSPHR, Medicinal and Pharmaceutical Chemistry University Of Toledo, 2009

Courses Taught Most Recent Academic Year

  • PHRM 8042

    Pharmacology & Therapeutics I
  • PHRM 9020

    Seminar in Pharmacology
  • MEDI 6220

    Cardiopulmonary/Heme
  • MEDI 6240

    GI/GU/Endocrine
  • PHRM 8043

    Pharmacology & Therapeutics II
  • NURO 9300

    Research in Neuroscience

Teaching Interests

Draws from research expertise to teach on the neuroscience of movement and the reward system. Clinical perspective is applied to movement disorders and drugs of abuse. Instruction also includes basic science methodology in these domains.

Scholarship

Selected Recent Publications

  • The G protein modifier KCTD5 tunes the decoding of neuromodulatory signals necessary for motor function in striatal neurons., 2025
    Journal Article, Academic Journal
  • Bmal1 Modulates Striatal cAMP Signaling and Motor Learning., 2025
    Journal Article, Academic Journal
  • Discrete spatiotemporal encoding of striatal dopamine transmission., 2025
    Journal Article, Academic Journal
  • Comprehensive medicinal chemistry survey highlights a portfolio of lead molecules for Alzheimer's disease therapy., 2025
    Journal Article, Academic Journal
  • Pathogenic variants in KCTD1 disrupt cAMP signaling and cellular communication associated with developmental pathways., 2025
    Journal Article, Academic Journal

Research Interests

Laboratory research focuses on the mechanisms underlying neuromodulation relevant for motor function. A strong interests pertains to emerging regulators of G Protein-Coupled Receptor signaling, particularly at the level of effectors such as Adenylyl Cyclase.